Sirolimus

Sibling codes

• XM0700 – Ozanimod
• XM09N4 – Imlifidase
• XM0V48 – Upadacitinib
• XM1835 – Teriflunomide
• XM1PC0 – Anifrolumab
• XM1PY3 – Alefacept
• XM1SM6 – Baricitinib
• XM2B74 – Ocrelizumab
• XM2Q51 – Antithymocyte immunoglobulin (rabbit)
• XM31G3 – Ravulizumab
• XM3F23 – Emapalumab
• XM3KK5 – Eculizumab
• XM3RJ6 – Peficitinib
• XM3TG8 – Antilymphocyte immunoglobulin (horse)
• XM45M8 – Abatacept
• XM4FP8 – Belatacept
• XM4RN7 – Abetimus
• XM57B1 – Mycophenolic acid
• XM5M04 – Leflunomide
• XM5MC2 – Vedolizumab
• XM69Y4 – Ponesimod
• XM6N55 – Siponimod
• XM6PD2 – Sutimlimab
• XM6QJ6 – Belumosudil
• XM75G0 – Gusperimus
• XM7BS8 – Begelomab
• XM7U27 – Tofacitinib
• XM8913 – Pegcetacoplan
• XM8AR9 – Teprotumumab
• XM8CX4 – Efalizumab
• XM93Q8 – Deucravacitinib
• XM9K56 – Fingolimod
• XM9M75 – Belimumab
• XM9RY3 – Muromonab-CD3
• XM9UD1 – Apremilast
• XM9YN4 – Natalizumab

Foundation entity

Sirolimus – http://id.who.int/icd/entity/436357614